PubRank

D L Cooper

Author PubWeight™ 68.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 1996 2.44
2 The evolution of alpha-fetoprotein and albumin. I. A comparison of the primary amino acid sequences of mammalian alpha-fetoprotein and albumin. J Biol Chem 1981 1.77
3 A national syndromic surveillance system for England and Wales using calls to a telephone helpline. Euro Surveill 2006 1.66
4 Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells. J Exp Med 1991 1.55
5 Bazex syndrome (acrokeratosis paraneoplastica). An analytic review. Medicine (Baltimore) 1991 1.49
6 Impact of non-CTCL dermatologic diagnoses and adjuvant therapies on cutaneous T-cell lymphoma patients treated with total skin electron beam radiation therapy. Int J Radiat Oncol Biol Phys 1994 1.44
7 High-dose BEAM chemotherapy with autologous peripheral blood progenitor-cell transplantation for unselected patients with primary refractory or relapsed Hodgkin's disease. Ann Oncol 2000 1.43
8 Alternative splicing of CD44 pre-mRNA in human colorectal tumors. Biochem Biophys Res Commun 1994 1.18
9 Clinical pharmacology and safety evaluation of Timentin. Am J Med 1985 1.12
10 Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. J Clin Oncol 2004 1.10
11 Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation. J Clin Oncol 1996 1.07
12 Ligand binding specificity of alternatively spliced CD44 isoforms. Recognition and binding of hyaluronan by CD44R1. J Biol Chem 1994 1.05
13 Degradation rates of acetylcholine receptors can be modified in the postjunctional plasma membrane of the vertebrate neuromuscular junction. J Cell Biol 1986 1.03
14 The Copper T 220C: a new long-acting copper intrauterine contraceptive device. Am J Obstet Gynecol 1976 0.99
15 Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients. Clin Exp Immunol 2012 0.95
16 Dosing and effectiveness of recombinant activated factor VII (rFVIIA) in congenital haemophilia with inhibitors by bleed type and location: the experience of the Haemophilia and Thrombosis Research Society (HTRS) Registry (2004-2008). Haemophilia 2012 0.95
17 Adhesive interactions between alternatively spliced CD44 isoforms. J Biol Chem 1995 0.94
18 Temocillin concentrations in human tissues. Drugs 1985 0.93
19 The variant mRNA isoform of human metastasis gene (CD44V) detected in the cell lines of human hepatocellular carcinoma. Biochem Mol Biol Int 1994 0.93
20 CD44V6 expression in human colorectal carcinoma. Hum Pathol 1998 0.92
21 Patient/caregiver-reported recombinant factor VIIa (rFVIIa) dosing: home treatment of acute bleeds in the Dosing Observational Study in Hemophilia (DOSE). Haemophilia 2011 0.91
22 RNA synthesis in myeloma cells synchronized by isoleucine starvation. Nucleic Acids Res 1978 0.91
23 Use of rituximab and irradiated donor-derived lymphocytes to control Epstein-Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantation. Bone Marrow Transplant 1999 0.89
24 Use of recombinant activated factor VII in patients with Glanzmann's thrombasthenia: a review of the literature. Haemophilia 2014 0.86
25 Thyroid lymphoma. The case for combined modality therapy. Cancer 1994 0.86
26 Gonorrhea screening program in a women's hospital outpatient department: results and analysis of risk factors. J Am Vener Dis Assoc 1976 0.85
27 Dermatomyositis and lichen myxedematosus. A clinical, histopathological and electron microscopic study. Dermatologica 1973 0.85
28 Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients. Antimicrob Agents Chemother 1983 0.84
29 Haemophilia Experiences, Results and Opportunities (HERO) Study: survey methodology and population demographics. Haemophilia 2013 0.84
30 Comparative analysis of three nucleic acid-based detection systems for hepatitis C virus RNA in plasma from liver transplant recipients. Mol Cell Probes 1996 0.84
31 Haemophilia Experiences, Results and Opportunities (HERO) Study: influence of haemophilia on interpersonal relationships as reported by adults with haemophilia and parents of children with haemophilia. Haemophilia 2014 0.84
32 Surgical experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX. Haemophilia 2011 0.84
33 A phase II study of outpatient chemotherapy with cisplatin, 5-fluorouracil, and leucovorin in nasopharyngeal carcinoma. Cancer 1994 0.84
34 A phase I study of paclitaxel for mobilization of peripheral blood progenitor cells. Bone Marrow Transplant 1999 0.82
35 Toxic erythema of chemotherapy following i.v. BU plus fludarabine for allogeneic PBSC transplant. Bone Marrow Transplant 2012 0.82
36 Screening recombinant DNA libraries: a rapid and efficient method for isolating cDNA clones utilizing the PCR. Biotechniques 1991 0.81
37 Pharmacokinetics of ticarcillin and clavulanic acid (timentin) in relation to renal function. Antimicrob Agents Chemother 1986 0.81
38 The multispecific cell adhesion molecule CD44 is represented in reticulocyte cDNA. Biochem Biophys Res Commun 1991 0.81
39 Exposure and safety of higher doses of recombinant factor VIIa ≥250 μg kg(-1) in individuals with congenital haemophilia complicated by alloantibody inhibitors: the Haemophilia and Thrombosis Research Society Registry experience (2004-2008). Haemophilia 2011 0.80
40 Assessing the impact of age, race, ethnicity and inhibitor status on functional limitations of patients with severe and moderately severe haemophilia A. Haemophilia 2011 0.80
41 Can scoring influence athletic performance? Sex and the athlete. J Am Coll Health Assoc 1975 0.80
42 Neutropenic infections in 100 patients with non-Hodgkin's lymphoma or Hodgkin's disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell transplant: out-patient treatment is a viable option. Bone Marrow Transplant 1999 0.80
43 Patient- and caregiver-reported bleeding symptoms and reasons for starting and stopping treatment with recombinant factor VIIa: analysis of the Dosing Observational Study in Haemophilia (DOSE). Haemophilia 2012 0.80
44 U.S. survey of surgical capabilities and experience with surgical procedures in patients with congenital haemophilia with inhibitors. Haemophilia 2011 0.80
45 Hyperleukocytosis and retinal hemorrhages after chemotherapy and Filgrastim administration for peripheral blood progenitor cell mobilization. Bone Marrow Transplant 1998 0.79
46 Recognizing otolaryngologic symptoms in patients with temporomandibular disorders. Cranio 1993 0.79
47 Assessment of individual dose utilization vs. physician prescribing recommendations for recombinant activated factor VII (rFVIIa) in paediatric and adult patients with congenital haemophilia and alloantibody inhibitors (CHwI): the Dosing Observational Study in Hemophilia (DOSE). Haemophilia 2013 0.79
48 Alternatively spliced CD44 isoforms containing exon v10 promote cellular adhesion through the recognition of chondroitin sulfate-modified CD44. Exp Cell Res 1999 0.79
49 Electromyography of masticatory muscles in craniomandibular disorders. Laryngoscope 1991 0.79
50 Prognostic significance of CD44 expression in adenocarcinoma of the lung. Clin Mol Pathol 1995 0.79
51 Assessment of cardiac and pulmonary function in adult patients with Hodgkin's disease treated with ABVD or MOPP/ABVD plus adjuvant low-dose mediastinal irradiation. Cancer Invest 1999 0.79
52 Haemophilia Experiences, Results and Opportunities (HERO) study: treatment-related characteristics of the population. Haemophilia 2014 0.79
53 DNA fingerprinting of crude bacterial lysates using degenerate RAPD primers. PCR Methods Appl 1995 0.79
54 Enzymatic and molecular diagnosis of Gaucher disease. Clin Lab Med 1995 0.78
55 Burkitt's lymphoma-leukemia in patients treated for Hodgkin's disease. Cancer Invest 1996 0.78
56 A simplified approach to stem cell mobilization in multiple myeloma patients not previously treated with alkylating agents. Bone Marrow Transplant 2003 0.78
57 Chlorambucil-induced seizures. Cancer 1997 0.78
58 Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: an analysis of the Hemophilia and Thrombosis Research Society Registry (2004-2008). Haemophilia 2010 0.78
59 P-glycoprotein expression and multidrug resistance in cutaneous T-cell lymphoma. Cancer Invest 2000 0.78
60 Second solid malignancies after combined modality therapy for Hodgkin's disease. J Clin Oncol 1995 0.78
61 Polyadenylation of RNA in a cell-free system from mouse myeloma cells. J Biol Chem 1978 0.78
62 Myofacial pain dysfunction: analysis of 476 patients. Laryngoscope 1986 0.78
63 Randomized comparative study of the copper T 300, Dalkon shield, and Shell Loop in parous women. Obstet Gynecol 1975 0.78
64 Health-related quality of life in haemophilia patients with inhibitors and their caregivers. Haemophilia 2012 0.78
65 Retention of CD44 introns in bladder cancer: understanding the alternative splicing of pre-mRNA opens new insights into the pathogenesis of human cancers. J Pathol 1995 0.78
66 Molecular mechanisms regulating the hyaluronan binding activity of the adhesion protein CD44. J Neurooncol 1995 0.77
67 Differential expressions of CD44 variants in tumors affecting the central nervous system. Mol Diagn 1999 0.77
68 Comparison of three different models of the copper T intrauterine contraceptive device. Am J Obstet Gynecol 1979 0.77
69 Interleukin-5 mRNA in three T-cell lymphomas with eosinophilia. Am J Hematol 1993 0.77
70 Editorial: Epileptics and contact sports. JAMA 1974 0.76
71 Gallium scans in the management of patients with Hodgkin's disease: a study of 101 patients. J Clin Oncol 1997 0.76
72 Diffuse recurrent herpes simplex virus skin lesions after adequate therapy with vidarabine. Pediatr Infect Dis 1986 0.76
73 Understanding the experience of caring for children with haemophilia: cross-sectional study of caregivers in the United States. Haemophilia 2014 0.76
74 Late solid tumors after treatment for Hodgkin's disease. J Clin Oncol 1998 0.75
75 Multidisciplinary approach to the differential diagnosis of facial, head and neck pain. J Prosthet Dent 1991 0.75
76 Application of the Cotswolds Criteria for the assessment of disease response in patients treated for Hodgkin's disease. J Clin Oncol 1995 0.75
77 Radiation for early-stage Hodgkin's disease? J Clin Oncol 2000 0.75
78 Re: Discordant pair analysis of rFVIIa and pd-aPCC response. Haemophilia 2011 0.75
79 Restoration of Dorsiflexion Following Distal Leg and Ankle Injuries. Phys Sportsmed 1977 0.75
80 Prevention of Tennis Elbow Through Conditioning. Phys Sportsmed 1977 0.75
81 Wrestling and weight fluctuations. J Am Coll Health Assoc 1973 0.75
82 Female athletics. JAMA 1974 0.75
83 Applications of momentum-space similarity. J Comput Aided Mol Des 1995 0.75
84 Long-term outcomes from orthopaedic surgery in haemophilia: are we measuring success and documenting and assessing complications? Haemophilia 2014 0.75
85 Gene therapeutic approach to primary and metastatic brain tumors: I. CD44 variant pre-RNA alternative splicing as a CEPT control element. J Neurooncol 1995 0.75
86 Traumatic Bursitis. Phys Sportsmed 1978 0.75
87 A community and school approach to drug prevention and early intervention with high risk elementary school children. J Prim Prev 1995 0.75
88 Allogeneic peripheral blood stem cell transplantation for high-risk non-Hodgkin's lymphoma. Bone Marrow Transplant 2003 0.75
89 The Role of Rest and Relaxation. Phys Sportsmed 1977 0.75
90 Managing the Pronated Foot. Phys Sportsmed 1979 0.75
91 Contact Dermatitis, Benzoin, and Athletic Tape. Phys Sportsmed 1978 0.75
92 Treatment of Hip Pointers. Phys Sportsmed 1978 0.75
93 Contrast Baths and Pressure Treatment for Ankle Sprains. Phys Sportsmed 1979 0.75
94 Preventing Chest and Upper Abdominal Pain Associated With Exercise. Phys Sportsmed 1977 0.75
95 A population-based trial of beta-carotene chemoprevention of head and neck cancer. Adv Exp Med Biol 1992 0.75
96 Drugs and the athlete. JAMA 1972 0.75
97 Target isotope effects for vibrationally-resolved electron capture in low-energy collisions of O3+ with molecular hydrogen. Faraday Discuss 2004 0.75
98 Nutrition in athletes. J Am Coll Health Assoc 1966 0.75
99 Modified insertion techniques for copper 7, copper T and progestasert intrauterine contraceptive devices. Contraception 1977 0.75
100 Ergogenic aids and drugs in athletics. J Am Coll Health Assoc 1972 0.75
101 Hip Abductors and Adductors in Rehabilitation. Phys Sportsmed 1977 0.75
102 Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study. Cancer J Sci Am 2006 0.75
103 Clinical study of a progesterone-releasing intrauterine contraceptive device. Am J Obstet Gynecol 1975 0.75
104 Gene therapeutic approaches to primary and metastatic brain tumors: II. ribozyme-mediated suppression of CD44 expression. J Neurooncol 1995 0.75
105 Guidelines for Knee Rehabilitation. Phys Sportsmed 1977 0.75
106 In vitro collection and posttransfusion engraftment characteristics of MNCs obtained by using a new separator for autologous PBPC transplantation. Transfusion 2000 0.75
107 Cardiac rhabdomyosarcoma. Conn Med 1988 0.75
108 A phase I pilot study of BCNU plus thymidine in patients with refractory cancer. Cancer Invest 1996 0.75
109 Treating the Charleyhorse. Phys Sportsmed 1979 0.75
110 President's address. J Am Coll Health Assoc 1968 0.75
111 The response of parathyroid hormone to specific changes in either ionized calcium, ionized magnesium, or protein-bound calcium in humans. Metabolism 1991 0.75
112 Phase II trial of 9-aminocamptothecin as a 72-h infusion in cutaneous T-cell lymphoma. Invest New Drugs 2001 0.75
113 Molecular diagnosis of cystic fibrosis. Clin Lab Med 1995 0.75
114 Modern valence-bond description of chemical reaction mechanisms: the 1,3-dipolar addition of diazomethane to ethene. J Org Chem 2001 0.75
115 Trainer's corner. Phys Sportsmed 1978 0.75
116 Protecting the Kidney. Phys Sportsmed 1979 0.75
117 Inhibition of poly(adenosine diphosphate-ribose) polymerase by thymidine and thymidine analogues in L1210 cells and its relationship to the potentiation of the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea but not of 3'-[3-(2-chloroethyl)-3-nitrosoureido]-3'-deoxythymidine. Cancer Res 1991 0.75
118 A new diagnostic test for Gaucher disease suitable for population screening. PCR Methods Appl 1994 0.75
119 Innovation: the mindset of risk taking. Mol Diagn 1999 0.75
120 Familial benign chronic pemphigus of perianal skin. Arch Dermatol 1971 0.75
121 Stretching Exercises for Flexibility. Phys Sportsmed 1977 0.75
122 Life table analysis of the effectiveness of contraceptive methods using an APL computer program. Int J Biomed Comput 1978 0.75
123 Pseudoleukemia after granulocyte colony-stimulating factor therapy. South Med J 1995 0.75
124 The issues change. It's the nature of science. Mol Diagn 1999 0.75
125 Nutrition in the athlete. Pa Med 1970 0.75
126 Turf Toe. Phys Sportsmed 1978 0.75
127 Assessment of pulmonary and cardiac function after high dose chemotherapy with BEAM and peripheral blood progenitor cell transplantation. Cancer 1998 0.75
128 Safety of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors: overall rFVIIa exposure and intervals following high (>240 μg kg⁻¹) rFVIIa doses across clinical trials and registries. Haemophilia 2014 0.75
129 High school football injuries. South Med J 1976 0.75
130 Impact of haemophilia with inhibitors on caregiver burden in the United States. Haemophilia 2014 0.75
131 Atrophie blanche in a patient with gamma-heavy-chain disease. Arch Dermatol 1991 0.75
132 What is fitness? Physical fitness, tranquility, and love of fellow man are essentials of happiness. R I Med J 1969 0.75
133 Multidisciplinary management of patients with haemophilia with inhibitors undergoing surgery in the United States: perspectives and best practices derived from experienced treatment centres. Haemophilia 2012 0.75
134 Editorial: Whither go the Olympics? JAMA 1976 0.75
135 The Human Genome Project: a generation's psyche and a society's revolution. Mol Diagn 2000 0.75
136 Restriction-fragment-length polymorphisms of 5'-flanking region of insulin I gene in BB and other rat strains. Absence of association with IDDM. Diabetes 1987 0.75
137 The promise and the dilemma of the new millennium. Mol Diagn 2000 0.75
138 Nabumetone pharmacokinetics in patients with varying degrees of renal impairment. Am J Med 1987 0.75
139 Flexibility for Tennis and Racquetball. Phys Sportsmed 1977 0.75
140 Developing and Testing Flexibility. Phys Sportsmed 1978 0.75
141 'Acupinch' for Muscle Cramps. Phys Sportsmed 1977 0.75